Interview preparation · MSL
The Medical Science Liaison interview is really four interviews stacked on top of each other: scientific depth, KOL judgement, behavioural evidence, and business acumen. This guide covers the questions hiring panels actually ask across all four, with model answers and STAR frameworks you can adapt to your therapeutic area.
For the scientific presentation round specifically, use the companion MSL presentation guide.
The panel is testing depth in the therapeutic area, not memorisation. Expect to be pushed on mechanism, competitor data, and unmet need, not just the paper you presented.
What they're testing
Whether you prepared beyond the press release, and whether you can pitch mechanism at KOL level without slides.
How to answer
Open with the pathway and the target, then the rationale for hitting it in this disease (biological + clinical), then how the molecule differentiates mechanistically from the current standard. Two minutes, no jargon dumps.
What they're testing
Structured recall under time pressure: design, primary endpoint, effect size, safety, one honest limitation.
How to answer
Design and population → primary endpoint and effect size with CI → key secondary → safety headline → one limitation. Rehearse this out loud for every asset on the company's near-term pipeline.
What they're testing
Whether you can think like a clinician, not just a scientist. They want a KOL-informed view, not a textbook one.
How to answer
Name one specific patient segment (e.g. second-line, elderly, biomarker-negative), the gap in current care, and a live trial or data readout that could change the picture in the next 12–18 months.
What they're testing
Competitive awareness plus the discipline to stay non-promotional while giving a sharp answer.
How to answer
Name the asset, its differentiating data (mechanism, endpoint, subgroup, dosing), and where the current company's asset still wins. Frame as scientific comparison, not sales positioning.
What they're testing
Audience calibration, a core MSL skill. Too technical loses the room; too shallow reads as junior.
How to answer
Use one analogy, one clinical anchor, and one 'so what' for the next patient. Practise the same explanation at three registers: KOL, community physician, and payer.
What they're testing
Whether you read the literature actively, and whether you can articulate scientific judgement.
How to answer
Pick a paper from the last 6 months. Say what you believed before, what the data showed, what you believe now, and one question it left open. Avoid vague 'interesting paper' framing.
Roughly a third of MSL interview questions probe field craft: territory planning, KOL relationships, insights, and advisory boards. Answer with specifics, territories, KOL counts, meeting cadence.
What they're testing
Whether you have a repeatable framework or you'll wander for three months.
How to answer
30 days: map the territory (tier 1–3 KOLs, institutions, ongoing trials, guideline authors). 60 days: initial meetings with all tier 1 KOLs and half of tier 2. 90 days: first insights synthesis to the medical team plus one advisory-board or educational touchpoint identified.
What they're testing
STAR + emotional intelligence. They want tension, judgement, and a real resolution, not a sanitised story.
How to answer
Situation (specific KOL and friction point) → Task (what you needed from the relationship) → Action (concrete step: scientific value-add, redirected topic, escalated internally) → Result (what changed, and what you learned about tailoring your approach).
What they're testing
Whether insights are a system for you or an afterthought.
How to answer
Same-day capture in the CRM with a standard structure (topic, KOL, insight, implication, action). Weekly synthesis by theme, not by KOL. Monthly written summary to medical, commercial, and market access with two or three prioritised actions.
What they're testing
Whether you understand advisory-board mechanics (charter, discussion guide, chairing, post-meeting synthesis), not just that you attended one.
How to answer
Name the topic, your specific role (content design, chairing a breakout, post-meeting report), the two or three insights that drove a decision, and how those insights were operationalised.
What they're testing
Compliance instincts under pressure, a non-negotiable for MSL hiring.
How to answer
Confirm the question is unsolicited, respond with on-label data first, and offer a Medical Information response for anything beyond label. Never provide off-label detail conversationally. Document the interaction.
What they're testing
Self-awareness and scientific confidence together.
How to answer
Depth on their specific research, honest acknowledgement of what you don't know, and one useful thing you bring to every interaction, a new dataset, a competitor readout, a cross-institution perspective they don't have.
These are scored strictly on structure. Prepare six to eight STAR stories that each cover multiple competencies so you can redeploy them under different question framings.
What they're testing
Cross-functional judgement, critical because MSLs sit between medical, commercial, market access, and clinical without formal authority over any of them.
How to answer
Pick a story where a peer or senior stakeholder initially disagreed. Show the data you brought, the framing you used, and the compromise or reversal you achieved. Name the business outcome.
What they're testing
Whether you'll be honest about a real miss, and whether you extract a repeatable lesson.
How to answer
Choose a real failure (missed insight, botched KOL meeting, blown timeline), not a humblebrag. Name the specific decision that went wrong, the cost, and one process change you made afterwards that you can point to today.
What they're testing
Medical/commercial firewall, a make-or-break competency for compliant field medical.
How to answer
Show that you engaged commercial's concern, restated the medical position with the underlying data, and offered an alternative path (Medical Information, KOL research, an advisory-board question) rather than shutting the conversation down.
What they're testing
Learning velocity, MSLs routinely re-tool for new launches.
How to answer
Describe your onboarding plan (papers, guidelines, KOL interviews, mock briefings), a specific time-boxed goal you set yourself, and the measurable competency you demonstrated (first solo KOL meeting, advisory-board contribution, internal training delivered).
What they're testing
Whether your insights actually land, the single highest-signal MSL question.
How to answer
Name the insight (KOL-sourced, specific, non-obvious), how you validated it, who you brought it to, and the decision it influenced (protocol amendment, positioning, launch tactic, resource shift). Quantify where you can.
Increasingly common at Senior MSL and Manager level. The panel wants to know you understand launch mechanics, KPIs, and how field medical connects to commercial outcomes.
What they're testing
Whether you distinguish activity metrics (touchpoints) from impact metrics (insights actioned, advisory-board contribution, KOL advocacy).
How to answer
Baseline activity: KOL coverage, meeting frequency, response times on Medical Information. Impact: number of insights actioned by medical or commercial, advisory-board and congress contributions, share of tier 1 KOLs actively engaged. Weight impact metrics heavier.
What they're testing
Launch readiness knowledge, a differentiator vs candidates who've only supported established assets.
How to answer
Pre-launch: scientific platform development, advisory boards, KOL mapping, IIT and RWE opportunities. Launch: peer-to-peer education, data dissemination at congresses, real-time insight capture. Post-launch: gap identification, evidence generation planning, competitive intelligence.
What they're testing
Compliance sophistication and business fluency together.
How to answer
Aligned on strategy, separated on execution. Medical owns the scientific narrative and unsolicited scientific exchange; commercial owns promotional messaging. Shared: advisory-board topics informed by both, insights synthesised jointly, KOL mapping.
What they're testing
Fit and self-awareness, and whether you understand the trade-offs.
How to answer
Biotech: ownership breadth, closer to development decisions, direct exposure to launch strategy. Pharma: infrastructure, therapeutic-area depth, mentorship. Name which you optimise for at this career stage and why.
Weak candidates ask about culture. Strong candidates ask questions that show they've read the pipeline and understand the field.
Why it lands
Forces the hiring manager to be concrete about expectations, and tells you whether they've thought about it themselves.
Why it lands
Signals you think about outcomes. Reveals how mature the field-medical function is.
Why it lands
Positions you as strategically aware and gives you real intelligence about the team's near-term priorities.
Why it lands
Probes whether this is a role you can build in, or a role restricted to peer-to-peer education.
Why it lands
Turns the interview into a scientific conversation, where MSL candidates outperform.
Why it lands
Shows you're thinking beyond the current job scope. Especially useful in Senior MSL and Manager interviews.
PharmaReady scores your CV, cover letter, and interview answers against the actual Medical Affairs role you're applying to, so your stories, your CV, and the questions the panel asks are aligned before you walk in.